Search results
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 20 hours agoIt even projects around $25 billion...additional annual revenue by 2030 from business development...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoCAR-T drugs are developed using a patient's own immune cells. Promisingly, Pfizer said in February...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 3 days agoRather, we believe stronger new launch performance and/or further progress on the...JPMorgan analyst...
Pfizer Stock Jumps On 'Massive' Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 3 days agoComirnaty, the Covid vaccine Pfizer developed with BioNTech (BNTX) brought in $354 million in sales,...
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 3 days agoPfizer Inc. (NYSE:PFE) reported its first-quarter financial results for 2024, indicating a solid...
Pfizer (PFE) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoWe believe Abrysvo has the potential to become the first and only RSV vaccine for adults 18 years and older. Hematology is another priority area. With...
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript Highlights: Navigating Post-COVID Challenges ...
GuruFocus.com via Yahoo Finance· 3 days agoA: (David M. Denton, CFO & EVP, Pfizer Inc.) Pfizer's primary capital allocation priorities are supporting and growing the dividend and deleveraging the ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 2 days agoNear the end of April, the company also announced a new innovation to integrate ...OpenAI’s press...
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend...
Motley Fool via Yahoo Finance· 5 days agoThe best way to describe why Pfizer stock recently hit multiyear lows is that it's been a victim of...
ESCMID 2024: Highlights on prophylaxis and treatment of infectious diseases
Clinical Trials Arena via Yahoo Finance· 4 days agoFollowing a near 60-year technological gap, two vaccines for the prevention of respiratory syncytial...